Dispense as written

To ensure brand name dispensing, preserver must write Dispense As Written on ... 

Mandatory drug product selection on the basis of price is common practice in the USA because third-party payers (insurance companies, health maintenance organizations, etc) enforce money-saving regulations. If outside a managed care organization, the prescriber can sometimes override these controls by writing "dispense as written" on a prescription... 

Professionals should educate their clients about the differences between generic and brand-name medications so that an educated choice can be made and clients will not think of the pill as something different or less effective. There are laws in virtually all states that allow pharmacists to substitute generic drugs for many brand-name products. Some states actually require that a generic must be substituted if it is available (Heidari, 2000). If a client does not want a generic medication or if the provider does not want the client to have one, the prescription should state this specifically. The social worker should check to see that the prescriber has written the words dispense as written or do not substitute so that the pharmacist is required to fill the prescription with the brand-name product requested. 

Pharmacists information - A oseiron may be dispensed only on presentation of a prescription for alosetron with a sticker for the prescribing program for alosetron attached. A MedGuide for alosetron must be given to the patient each time alosetron is dispensed as required by law. No telephone, facsimile, or computerized prescriptions are permitted with this program. Refills are permitted to be written on prescriptions. 

When dispensing nasal preparations the patient should receive all relevant information, oral as well as written. 

Pharmacogenomics will further expand the responsibility of pharmacists to screen prescriptions, because physicians will have more opportunities for error in prescribing, just as pharmacists will have more opportunities for error in dispensing. Knowing whether the physician has written a prescription correctly for a patient will require that pharmacists evaluate patient-specific genetic information in addition to the other patient-related information that pharmacists currently have available for analysis. This may... 

To prevent the mistake of overlooking a decimal point, precede the decimal point with a zero if the value is less than one, i.e., writing 0.8 g is better than. 8 g. As a practical example, if a prescription is written for Dexamethasone Oral Solution. 5 mg/.5 mL, one possible mistake could be dispensing 0.5 mg/5 mL solution. This under-medication to the patient would most likely be avoided if 0.5 mg/0.5 mL is written. 

The Subscription represents the directions to the dispenser and indicates the type of dosage form or the number of dosage units. For compounded prescriptions, the subscription is written using English or Latin abbreviations. A few examples are provided as follows ... 

Tenormin is available in a strength of 50 mg. If a prescription is written for 100 mg daily for three weeks as directed, how many tablets should be dispensed ... 

The medicinal, or therapeutic, uses of codeine are to relieve pain, to suppress cough, and to control diarrhea (see Chapters 2 and 3). Because of its usefulness and availability as an oral medication (as opposed to an injectable medication), codeine may be the single most commonly dispensed prescription medicine in the United States. In 2004, the last full year for which data are available, more than 157 million prescriptions were written for codeine. This number of prescriptions was the highest of the 20 most-prescribed therapeutic categories. Prescriptions for codeine, and codeine-containing medicines, accounted for 3.3 billion dollars of pharmaceutical sales in the United States in 2004. Preliminary data show that the number of prescriptions for codeine for the nine-month period January to September 2005 is more than 164 million, so the drug continues to gain in popularity. 

The review of the protocol ensures that there are adequate selection criteria and procedures to protect vulnerable study populations. In addition, information within the protocol, the informed consent, and the Investigator s Brochure are reviewed to assess safety information that may affect subjects. Institutional review boards are empowered with the authority to approve or disapprove research activities that are covered by regulations, as well as to require modifications to secure approval. Informed consents will be reviewed to assure that all the information provided is in accordance with 21 CFR 50.25 the IRB may also require that additional information be provided to study subjects in a separate format, such as a patient information sheet. If this requirement is waived, a written statement may be given to the subject. If a very short window of opportunity exists to dispense a research treatment to avoid a devastating or fatal outcome, a waiver for this requirement may be requested. It is important to note, however, that the sponsor must clearly describe or define the situations that would require testing without administering a written informed consent. Also, provisions that will be made to obtain the consent from family members must be in place. This issue will be discussed in more detail in the section on informed consent. In summary, the following criteria are used by IRBs to approve research ... 

Another development in the seventeenth century was the proliferation of alchemical books. Certain publishers, notably De Bry of Frankfurt, printed almost nothing else. Apart from Michael Maier s Atalanta Fugiens, other celebrated works included the Book of Lambspring (1599), Heinrich Khunrath s Ampitheatre of Eternal Wisdom (1609), and Altus s Mutus Liber (1677), an illustrated book that almost entirely dispensed with a written text. Encyclopaedic compendia appeared, such as the Theatrum Chemicum (1602), and the Theatrum Chemicum Britannicum (1652), edited by Elias Ashmole. 

This book, written with a definite clinical bias (as the editors and contributors are practising prescribers from a range of disciplines), is designed to be an easily accessible reference for busy prescribers/dispensers who may not have access to, or the time to search, the more comprehensive resources on adverse drug-drug interactions both in print and online. We have considered interactions which we... 

In contrast to a publication, however, it does not need to be elegant or linguistically polished on the contrary, in the interests of time, these refinements should be dispensed with, so long as clarity does not suffer. It should be emphasised again that the experimental account should be written up largely in parallel with the work that means that it must necessarily be kept condse. 

The proprietary name is a trade mark applied to particular formulation(s) of a particular substance by a particular manufacturer. Manufacture is confined to the owner of the trade mark or to others licensed by the owner. It is designed to maximise the difference between the names of similar drugs marketed by rivals for obvious commercial reasons. To add confusion, some companies give their proprietary products the same names as their generic products in an attempt to capture the prescription market, both proprietary and generic, and some market lower-priced generics of their own proprietaries. When a prescription is written for a proprietary product, pharmacists under UK law must dispense that product only. But by agreement... 

From here on we dispense with vectorial notation, on the assumption that the material is isotropic. Note that on integrating over the field at constant entropy the temperature of the system necessarily increases, so that, in contrast to the earlier treatment, ao(T, V) now changes during integration. In fact, since the entropy has the functional dependence S = S T, V, q) we must first invert this relation to specify T = T(S, V, q), so that the polarizability is written out as ao(S(T, V, q), V). We then integrate (5.7.12) by parts to find... 

Space must be provided on the outer packing for indication of the pharmacy dispensing the prescribed product and for written instructions for the patient as per the physician s prescription. 

TTOs are either written on a specific section of the patient s drug chart (see Figure 4.3) or on hospital-specific forms (see Figure 4.5). TTOs require the same information as an NHS prescription form (see list below), the difference being that these may only be dispensed within the hospital. 

---